rs4648127 — NFKB1 NFKB1 intronic variant

NF-κB1 Intronic Variant — A Rare Protective Signal in the Immune Master Switch

The NFKB1 gene encodes NF-κB1 (Nuclear Factor kappa-light-chain-enhancer of activated B cells subunit 1)¹¹ NF-κB1 (Nuclear Factor kappa-light-chain-enhancer of activated B cells subunit 1)
A key transcription factor that controls hundreds of immune and inflammatory genes in response to pathogen detection, the essential p105/p50 subunit of the canonical NF-κB signaling complex. When Toll-like receptors and NOD-like receptors detect pathogen components, they trigger signaling cascades that liberate p50-p65 dimers to enter the nucleus and activate innate immune genes including cytokines, antimicrobial peptides, and co-stimulatory molecules. rs4648127 is an intronic variant in NFKB1 at chromosome 4 position 102,614,748 (GRCh38). The T allele at this position is uncommon (~5.8% in Europeans) and was identified in a systematic candidate-gene study as independently associated with reduced lung cancer risk — making it one of the few common genetic variants at the NFKB1 locus where the minor allele confers protection rather than susceptibility.

The Mechanism

rs4648127 lies within an intron of NFKB1 and does not alter the protein sequence of p105 or p50. Intronic variants at this locus are thought to influence regulatory elements — splicing factor binding sites, enhancers, or transcription factor binding sequences embedded in intronic DNA — that tune NFKB1 expression levels or splicing efficiency. The precise molecular mechanism for rs4648127 has not been characterized at the protein or transcript level. Its position within the NFKB1 locus places it in a genomic region that harbors multiple linkage disequilibrium²² linkage disequilibrium
The non-random co-inheritance of alleles at nearby chromosomal positions; variants in LD tend to be co-inherited as a block blocks associated with immune function and infection susceptibility. The nearby functional variant rs28362491 (a 4-bp ATTG insertion-deletion in the NFKB1 5' regulatory region) is one candidate for the causal signal; rs4648127 may tag independent regulatory variation or reflect the same underlying functional effect through partial LD.

The direction of association for rs4648127 is notable: whereas rs230523 (another intronic NFKB1 variant) shows a susceptibility signal (C allele → increased infection risk), rs4648127 shows the opposite — the T allele appears protective against lung cancer. This divergent directionality across two variants in the same gene suggests the NFKB1 intronic region contains multiple partially independent regulatory elements that differentially affect immune gene expression in different tissue contexts or along different pathogen-response axes.

The Evidence

Shiels et al. (2012)³³ Shiels et al. (2012)
Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk. Cancer. conducted a systematic two-stage study: first screening 1,429 SNPs across innate immunity and inflammation genes in 378 lung cancer cases and 450 controls from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), then replicating top signals in an independent GWAS dataset. Of 81 SNPs initially significant, only rs4648127 in NFKB1 survived multiple testing correction. The CT/TT genotype was associated with an odds ratio of 0.56 (95% CI: 0.37–0.86) in the PLCO discovery cohort and 0.79 (95% CI: 0.69–0.90) in the GWAS replication. The protective direction was consistent across both datasets.

Curtin et al. (2010)⁴⁴ Curtin et al. (2010)
Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor. BMC Medical Genetics. included rs4648127 among NFKB1 haplotype variants in a multilocus analysis of colorectal cancer susceptibility, examining how combinations of NFKB1, IKBKB, and IL6 variants interact to affect colon cancer risk.

Slattery et al. (2011)⁵⁵ Slattery et al. (2011)
Interferon-signaling pathway associations with colon and rectal cancer risk. Carcinogenesis. examined NFKB1 variants as pathway interaction partners in 1,555 colon cancer cases and 754 rectal cancer cases, finding that NF-κB1 variants significantly interact with interferon-pathway components to modulate colorectal cancer susceptibility.

The broader NFKB1 locus context is established by two large studies: Tian et al. (2017)⁶⁶ Tian et al. (2017) — a 23andMe GWAS of infection susceptibility in >200,000 Europeans identifying the NFKB1 locus as genome-wide significant for overall infection risk — and Chong et al. (2024)⁷⁷ Chong et al. (2024) — a UK Biobank serology-based GWAS in 487,297 participants finding NFKB1 as the top locus influencing antibody responses to herpesviruses and polyomaviruses.

Practical Actions

The rs4648127 T allele is protective against lung cancer with an OR of ~0.79 in the GWAS replication — a reduction in relative risk of approximately 21% per protective allele copy. For CT heterozygotes, this represents meaningful but partial protection; for the rare TT homozygotes, the full protective effect applies. Importantly, this genetic protection operates through immune surveillance mechanisms, not through reduction in carcinogen exposure. The protective allele does not eliminate lung cancer risk from environmental exposures such as tobacco smoke or occupational carcinogens — it modulates how the immune system recognizes and responds to transformed cells. Carriers should avoid over-relying on this genetic signal as license to ignore environmental risk factors for lung cancer.

The variant does not alter standard innate immunity recommendations for infection prevention, which are covered by the nearby NFKB1 variant rs230523.

Interactions

rs4648127 is physically close to rs230523 on chromosome 4 within the same NFKB1 locus. These two variants show different association directions (rs230523 C allele → susceptibility; rs4648127 T allele → protection), suggesting they may tag distinct functional elements within the NFKB1 regulatory landscape. Users who carry the rs230523 C susceptibility allele and the rs4648127 T protective allele face partially offsetting effects: one variant subtly reducing NF-κB1 immune activation, the other associated with improved immune surveillance of malignant cells.

The most studied functional variant at this locus is rs28362491 (the -94ATTG regulatory insertion-deletion). Its LD relationship with rs4648127 has not been fully characterized in published literature, so the two should be interpreted as potentially independent signals until formal LD mapping is available.